Indeterminate T-SPOT.TB Test Results in Patients with Suspected Extrapulmonary Tuberculosis in Routine Clinical Practice
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: The two interferon-γ release assays such as QuantiFERON-TB Gold / In-Tube (QFT-TB) and T-SPOT.TB -are useful tools for the rapid diagnosis of tuberculosis (TB) but can yield indeterminate test results (ITRs). While some studies have identified risk factors for ITRs in the QFT-TB test, there have been few such studies for the T-SPOT.TB test. The aim of this study was to investigate the risk factors associated with ITRs in the T-SPOT.TB test. Materials and Methods: From April 2008 to August 2010, all patients with suspected extrapulmonary tuberculosis (E-TB)were enrolled in a tertiary hospital in Korea. ITR was defined as < 20 spots in the positive control well or > 10 spots in the negative control well. Results: Out of a total of 368 patients, 32 (8.7%, 95% CI, 6.0% to 11.7%) had ITRs in their T-SPOT.TB tests. The ITRs were due to a low mitogen response in 13 (40.6%) patients and to a high nil response in the other 19 (59.4%) patients. Statistical analysis revealed that old age, underlying diseases, immunosuppressive treatment, lymphopenia, and clinical manifestations of E-TB were not significantly associated with ITRs. Conclusions: Indeterminate results in the T-SPOT.TB test are not affected by age, underlying disease, immunosuppressive treatment,lymphopenia, or clinical manifestations of E-TB, which are known risk factors for indeterminate results in the QFT-TB test.
Abstract
Background: The two interferon-γ release assays such as QuantiFERON-TB Gold / In-Tube (QFT-TB) and T-SPOT.TB -are useful tools for the rapid diagnosis of tuberculosis (TB) but can yield indeterminate test results (ITRs). While some studies have identified risk factors for ITRs in the QFT-TB test, there have been few such studies for the T-SPOT.TB test. The aim of this study was to investigate the risk factors associated with ITRs in the T-SPOT.TB test. Materials and Methods: From April 2008 to August 2010, all patients with suspected extrapulmonary tuberculosis (E-TB)were enrolled in a tertiary hospital in Korea. ITR was defined as < 20 spots in the positive control well or > 10 spots in the negative control well. Results: Out of a total of 368 patients, 32 (8.7%, 95% CI, 6.0% to 11.7%) had ITRs in their T-SPOT.TB tests. The ITRs were due to a low mitogen response in 13 (40.6%) patients and to a high nil response in the other 19 (59.4%) patients. Statistical analysis revealed that old age, underlying diseases, immunosuppressive treatment, lymphopenia, and clinical manifestations of E-TB were not significantly associated with ITRs. Conclusions: Indeterminate results in the T-SPOT.TB test are not affected by age, underlying disease, immunosuppressive treatment,lymphopenia, or clinical manifestations of E-TB, which are known risk factors for indeterminate results in the QFT-TB test.
참고문헌 (31)
- Dye C, "Evolution of tuberculosis control and prospects for reducingtuberculosis incidence, prevalence, and deaths globally", JAMA, 293, pp.2767~2775 (2005)
- Mazurek GH, "Updated guidelines for using InterferonGamma Release Assays to detect Mycobacterium tuberculosisinfection - United States, 2010", MMWR RecommRep, 59, pp.1~25 (2010)
- Kim SH, "Diagnosticusefulness of a T-cell based assay for extrapulmonarytuberculosis", Arch Intern Med, 167, pp.2255~2259 (2007)
- Mazurek GH, "CDC. Guidelines for using theQuantiFERON-TB test for diagnosing latent Mycobacteriumtuberculosis infection. Centers for Disease Control and Prevention", MMWR Recomm Rep, 52, pp.15~18 (2003)
- Mazurek GH, "Division of Tuberculosis Elimination, NationalCenter for HIV, STD, and TB Prevention, Centers for DiseaseControl and Prevention (CDC). Guidelines for using theQuantiFERON-TB Gold test for detecting Mycobacteriumtuberculosis infection, United States", MMWR Recomm Rep, 54, pp.49~55 (2005)
- Cho OH, "Diagnostic usefulnessof a T-cell-based assay for osteoarticular tuberculosis", JInfect, 61, pp.228~234 (2010)
- Kim SH, "Diagnosis of abdominal tuberculosisby T-cell-based assays on peripheral blood and peritonealfluid mononuclear cells", J Infect, 59, pp.409~415 (2009)
- Wang JY, "Diagnosis of tuberculosis by an enzyme-linkedimmunospot assay for interferon-gamma", Emerg Infect Dis, 13, pp.553~558 (2007)
- Tan CK, "Diagnosis of active tuberculosis by enzyme-linkedimmunospot assay for interferon-gamma in HIV-infected patients", J Acquir Immune Defic Syndr, 53, pp.546~547 (2010)
- Kim SH, "Diagnosis of central nervoussystem tuberculosis by T-cell-based assays on peripheralblood and cerebrospinal fluid mononuclear cells", Clin VaccineImmunol, 15, pp.1356~1362 (2008)
- Kim SH, "Diagnostic usefulness of a T-cell-based assay for extrapulmonarytuberculosis in immunocompromised patients", Am J Med, 122, pp.189~195 (2009)
- Lai CC, "Diagnosis of peripheral tuberculous lymphadenitis by enzyme-linked immunospot assay for interferon-gamma", AmJ Med, 122, pp.5~6 (2009)
- Diel R, "Evidence-basedcomparison of commercial interferon-gamma releaseassays for detecting active TB: a metaanalysis", Chest, 137, pp.952~968 (2010)
- Kim SH, "Rapid diagnosis oftuberculous meningitis by T cell-based assays on peripheralblood and cerebrospinal fluid mononuclear cells", ClinInfect Dis, 50, pp.1349~1358 (2010)
- Sester M, "Interferon-γ release assays for the diagnosis of activetuberculosis: a systematic review and meta-analysis", EurRespir J, 37, pp.100~111 (2011)
- Park KH, "T-cell-based assays on cerebrospinalfluid and PBMCs for rapid diagnosis of TB meningitisin non-HIV patients", Eur Respir J, 39, pp.768~770 (2012)
- Cho OH, "Diagnostic performance of T-SPOT.TB for extrapulmonarytuberculosis according to the site of infection", J Infect, 63, pp.362~369 (2011)
- Lee JY, "Comparisonof two commercial interferon-gamma assays for diagnosingMycobacterium tuberculosis infection", Eur Respir J, 28, pp.24~30 (2006)
- Meier T, "Sensitivity of a new commercial enzyme-linkedimmunospot assay (T SPOT-TB) for diagnosis of tuberculosisin clinical practice", Eur J Clin Microbiol Infect Dis, 24, pp.529~536 (2005)
- Beffa P, "Indeterminate test results of T-SPOT.TB performedunder routine field conditions", Eur Respir J, 31, pp.842~846 (2008)
- Ferrara G, "Routine hospital use of a new commercialwhole blood interferon-gamma assay for the diagnosisof tuberculosis infection", Am J Respir Crit Care Med, 172, pp.631~635 (2005)
- Kang YA, "Usefulness of whole-blood interferon-gamma assayand interferon-gamma enzyme-linked immunospot assayin the diagnosis of active pulmonary tuberculosis", Chest, 132, pp.959~965 (2007)
- Richeldi L, "Performanceof tests for latent tuberculosis in different groupsof immunocompromised patients", Chest, 136, pp.198~204 (2009)
- Kobashi Y, "Indeterminate results of QuantiFERON TB-2G test performedin routine clinical practice", Eur Respir J, 33, pp.812~815 (2009)
- Kobashi Y, "Clinical evaluation of QuantiFERON TB-2G test for immunocompromisedpatients", Eur Respir J, 30, pp.945~950 (2007)
- Jeong SJ, "Predictive factors for indeterminateresult on the QuantiFERON test in an intermediatetuberculosis-burden country", J Infect, 62, pp.347~354 (2011)
- Marais S, "Tuberculousmeningitis: a uniform case definition for use in clinical research", Lancet Infect Dis, 10, pp.803~812 (2010)
- Toh BH, "Depression of cell-mediated immunity in oldage and the immunopathic diseases, lupus erythematosus,chronic hepatitis and rheumatoid arthritis", Clin Exp Immunol, 14, pp.193~202 (1973)
- Casas I, "Evaluation of interferon-gamma release assays in the diagnosisof recent tuberculosis infection in health care workers", PLoS One, 4, pp.e6686~ (2009)
- Latorre I, "Evaluating the nontuberculousmycobacteria effect in the tuberculosis infectiondiagnosis", Eur Respir J, 35, pp.338~342 (2010)
- Ferrara G, "Use in routine clinicalpractice of two commercial blood tests for diagnosis ofinfection with Mycobacterium tuberculosis: a prospectivestudy", Lancet, 367, pp.1328~1334 (2006)